Overview

Myocarditis Treatment Trial

Status:
Completed
Trial end date:
1994-03-01
Target enrollment:
Participant gender:
Summary
To determine whether immunosuppressive treatment improved cardiac function in patients with biopsy-proven myocarditis.
Phase:
Phase 2
Details
Lead Sponsor:
University of Utah
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Cyclosporine
Cyclosporins
Prednisone